Cargando…
Valproate Alters Dopamine Signaling in Association with Induction of Par-4 Protein Expression
Chromatin remodeling through histone modifications has emerged as a key mechanism in the pathophysiology of psychiatric disorders. Valproate (VPA), a first-line medication for bipolar disorder, is known to have histone deacetylase (HDAC) inhibitor activity, but the relationship between its efficacy...
Autores principales: | Lee, Saebom, Jeong, Jaehoon, Park, Young-Un, Kwak, Yongdo, Lee, Seol Ae, Lee, Haeryun, Son, Hyeon, Park, Sang Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454414/ https://www.ncbi.nlm.nih.gov/pubmed/23029138 http://dx.doi.org/10.1371/journal.pone.0045618 |
Ejemplares similares
-
Correction: Valproate Alters Dopamine Signaling in Association with Induction of Par-4 Protein Expression
por: Lee, Saebom, et al.
Publicado: (2014) -
Cdk5 Phosphorylates Dopamine D2 Receptor and Attenuates Downstream Signaling
por: Jeong, Jaehoon, et al.
Publicado: (2013) -
Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010) -
Regulation of the actin cytoskeleton by the Ndel1-Tara complex is critical for cell migration
por: Hong, Ji-Ho, et al.
Publicado: (2016) -
Dopamine D1 Receptor (D1R) Expression Is Controlled by a Transcriptional Repressor Complex Containing DISC1
por: Suh, Yeongjun, et al.
Publicado: (2019)